ENG and neoplasm: Studies using CD105-targeted molecular imaging probes have achieved a tumor-to-muscle ratio of up to 300, allowing precise tumor visualization and removal of residual cancer cells, ensuring thorough yet conservative resections and setting a benchmark for imaging-guided surgery (49).